Mr. Speaker, I met with the Canadian Pharmacists Association. I also asked my department to look into effective ways of predicting possible shortages.
As a regulator of prescription drugs, we are responsible for assessing the safety and efficacy of the quality of drugs and products that are sold in Canada. We are continuing to look at this very issue with the department and the association.